Pharmaron Beijing Co., Ltd. (3759.HK)
HKD 13.72
(3.94%)
HKD 13.72
(3.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.75 Billion | 2.14 Billion | 2.05 Billion | 1.64 Billion | 938.58 Million | 737.25 Million |
| Net Income | 1.58 Billion | 1.35 Billion | 1.62 Billion | 1.14 Billion | 530.67 Million | 339.02 Million |
| Depreciation & Amortization | 927.17 Million | 696.17 Million | 497.92 Million | 375.16 Million | 317.66 Million | 211.69 Million |
| Deferred income taxes | -202.22 Million | -177.17 Million | -67.52 Million | -62.45 Million | -11.52 Million | - |
| Stock-based compensation | 202.22 Million | 177.17 Million | 67.52 Million | 62.45 Million | 11.52 Million | - |
| Change in working capital | 34.55 Thousand | -346.46 Million | 130.03 Million | 234.58 Million | -61.11 Million | 43.07 Million |
| Other non-cash items | 244.55 Million | 440.96 Million | -189.99 Million | -108.12 Million | 151.36 Million | 143.46 Million |
| Investing Cash Flow | -2.25 Billion | -2.2 Billion | -5.25 Billion | -3.37 Billion | -1.04 Billion | -714.6 Million |
| Investments in PPE | -2.86 Billion | -2.94 Billion | -2.09 Billion | -1.31 Billion | -754.6 Million | -640.98 Million |
| Acquisitions | 8.11 Million | -1.02 Billion | -1.23 Billion | -791.52 Million | -59.49 Million | - |
| Investment purchases | -2.11 Billion | -2.33 Billion | -4.92 Billion | -2.63 Billion | -693.94 Million | -95.99 Million |
| Sales/Maturities of investments | 2.72 Billion | 4.09 Billion | 2.98 Billion | 1.39 Billion | 491.34 Million | - |
| Other Investing Activities | -667.49 Thousand | 3.15 Million | 5.48 Million | -18.54 Million | -28.5 Million | 22.38 Million |
| Financing Cash Flow | 3.91 Billion | -1.41 Billion | 3.66 Billion | -280.17 Million | 4.24 Billion | -15.55 Million |
| Debt repayment | -559.13 Million | -612.57 Million | -158.55 Million | -760.96 Million | -1.28 Billion | -423.68 Million |
| Dividends payments | -444.79 Million | -404.76 Million | -284.71 Million | -135.4 Million | -143.19 Million | -74.59 Million |
| Common Stock Repurchased | -830.02 Thousand | -393.38 Million | -284.05 Million | - | - | - |
| Common Stock Issuance | - | 393.38 Million | 284.05 Million | - | - | - |
| Other Financing Activities | 4.91 Billion | -399.92 Million | 4.1 Billion | 616.18 Million | 5.67 Billion | 482.71 Million |
| Accounts receivables | -480.1 Million | -830.62 Million | -295.65 Million | -95.34 Million | -278.07 Million | -173.42 Million |
| Accounts payables | 480.1 Million | 830.62 Million | 295.65 Million | 95.34 Million | 278.07 Million | - |
| Inventory | 82.42 Million | -120.89 Million | -224.87 Million | -120.04 Million | -37.95 Million | -28.28 Million |
| Other working capital | -82.39 Million | -225.57 Million | 354.91 Million | 354.63 Million | -23.16 Million | 71.36 Million |
| Cash at beginning of period | 1.35 Billion | 2.76 Billion | 2.35 Billion | 4.44 Billion | 307.23 Million | 293.6 Million |
| Cash at end of period | 5.78 Billion | 1.35 Billion | 2.76 Billion | 2.35 Billion | 4.44 Billion | 307.23 Million |
| Capital Expenditure | -2.86 Billion | -2.94 Billion | -2.09 Billion | -1.31 Billion | -754.6 Million | -640.98 Million |
| Effect of forex changes on cash | 11.43 Million | 72.99 Million | -45.51 Million | -85.66 Million | -4.27 Million | 6.53 Million |
| Net cash flow / Change in cash | 4.42 Billion | -1.4 Billion | 415.77 Million | -2.08 Billion | 4.13 Billion | 13.63 Million |
| Free Cash Flow | -111.78 Million | -807.04 Million | -34.77 Million | 332.77 Million | 183.98 Million | 96.27 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 882.84 Million | 230.55 Million | 1.58 Billion | 462.05 Million | 352.94 Million |
| Depreciation & Amortization | - | 554.81 Million | - | 927.17 Million | 916.38 Million | -440.91 Million |
| Deferred income taxes | - | - | - | -202.22 Million | 2.00 | -260.81 Million |
| Stock-based compensation | - | 75.37 Million | 32.91 Thousand | 202.22 Million | 57 Million | 19.87 Million |
| Change in working capital | - | -62.85 Million | - | 34.55 Thousand | -195.45 Million | 240.93 Million |
| Other non-cash items | - | -1.09 Billion | 515.03 Million | 244.55 Million | -515.86 Million | 837.16 Million |
| Investing Cash Flow | -886.79 Million | 456.44 Million | -467.09 Million | -2.25 Billion | -442.96 Million | -989.92 Million |
| Investments in PPE | -548.87 Million | -451.59 Million | -498.61 Million | -2.86 Billion | -624.78 Million | -739.73 Million |
| Acquisitions | - | - | - | 8.11 Million | 0.07 | 1.18 |
| Investment purchases | -322.19 Million | -336.68 Million | -1.07 Billion | -2.11 Billion | -438.96 Million | -260.8 Million |
| Sales/Maturities of investments | 12.69 Million | 1.24 Billion | 1.11 Billion | 2.72 Billion | 619.15 Million | 4.95 Million |
| Other Investing Activities | -28.41 Million | 908.03 Million | 31.52 Million | -667.49 Thousand | 1.62 Million | 5.64 Million |
| Financing Cash Flow | -132.92 Million | -3.14 Billion | -1.51 Billion | 3.91 Billion | 3.48 Billion | -209.97 Million |
| Debt repayment | -78.99 Million | -2.6 Billion | -1.4 Billion | -559.13 Million | -91.04 Million | -110.86 Million |
| Dividends payments | -109.63 Million | -343.2 Million | -46.3 Million | -444.79 Million | -49.66 Million | -368.09 Million |
| Common Stock Repurchased | - | -151.12 Million | - | -830.02 Thousand | -830.02 Thousand | -860 Million |
| Common Stock Issuance | - | - | - | - | - | 860 Million |
| Other Financing Activities | -102.28 Million | -192.62 Million | -60.34 Million | 4.91 Billion | 3.62 Billion | 268.99 Million |
| Accounts receivables | - | 36.37 Million | - | -480.1 Million | -480.1 Million | 285.11 Million |
| Accounts payables | - | - | - | 480.1 Million | - | 125.33 Million |
| Inventory | - | -174.63 Million | - | 82.42 Million | 82.42 Million | -44.18 Million |
| Other working capital | - | 75.4 Million | - | -82.39 Million | 202.22 Million | -125.33 Million |
| Cash at beginning of period | 2.28 Billion | 4.56 Billion | 5.78 Billion | 1.35 Billion | 2.02 Billion | 2.47 Billion |
| Cash at end of period | 1.93 Billion | 2.28 Billion | 4.56 Billion | 5.78 Billion | 5.78 Billion | 2.02 Billion |
| Capital Expenditure | -548.87 Million | -451.59 Million | -498.61 Million | -2.86 Billion | -624.78 Million | -739.73 Million |
| Effect of forex changes on cash | -2.32 Million | 51.17 Million | 6.45 Million | 11.43 Million | 1.32 Million | -2.03 Million |
| Net cash flow / Change in cash | -351.26 Million | -2.27 Billion | -1.22 Billion | 4.42 Billion | 3.76 Billion | -452.73 Million |
| Free Cash Flow | -548.87 Million | -97.48 Million | 247.01 Million | -111.78 Million | 99.35 Million | 9.46 Million |
TKYMY
GDA
ALIMP
SCT
OCLDF
CABP